Professional Documents
Culture Documents
B. New model:
a. Marketing : good distribution, product awareness, development of
marketing and sales force
b. Competitive pricing
Problems identified:
Way ahead:
1. Align the processes of the company with its newly designed strategy. The
company and its employees should shun the start-up culture and adopt a
formal culture of a commercial firm. For this purpose, company can
introduce a formal performance management system,
2. Since millennium is a new entrant in commercial drug development, they
should focus on a limited disease portfolio and establish themselves as
market leader in that profile first rather than focussing on multiple disease
portfolio. Identify drugs whose development and commercialization would
give competitive edge to the company.
3. Upon transition from being a biotech start up to a drug selling company, a
formal performance management system should be introduced. This will
ensure that appropriate employees are held accountable for their
decisions and actions. Employees should be communicated their goals and
deliverables clearly, so that the compensation can be based on their
achievements.
4. In order to fill the position of R&D head, CEO Dunsire should rope in
somebody who has expertise in both research as well as the mindset of
developing commercial product. This will ensure that the R&D department
of the company is in synergy with the companys strategy. For this
purpose, an internal promotion would be a viable option, ensuring that the
employees do not retaliate against the new CEO. This will also ensure that
the employees stay loyal to the organization and do not leave it.
5. Marketing team should be developed and assigned to every disease
portfolio in which the company deals. Separate teams would ensure that
the sales reps have in-depth knowledge of their product and adopt a
focussed approach for making their sales.
6. The resource allocation to commercial and R&D platforms should be
optimized. The company should allocate more funds for the commercial
opportunities. In order to ensure that future product development is not
jeopardised, company can revive their potential leads in which they
invested during their research venture.